Recent Developments Using Small Molecules to Target RAD51: How to Best Modulate RAD51 for Anticancer Therapy?-Reference-Cited by-同舟云学术

Recent Developments Using Small Molecules to Target RAD51: How to Best Modulate RAD51 for Anticancer Therapy?

Published:2016-10-26 Issue:22 Volume:11 Page:2468-2473
ISSN:1860-7179
Container-title:ChemMedChem
language:en
Short-container-title:ChemMedChem

Author:

Budke Brian¹,Lv Wei²,Kozikowski Alan P.²,Connell Philip P.¹

Affiliation:

1. Department of Radiation and Cellular Oncology; University of Chicago; 5841 S. Maryland Ave. Chicago IL 60637 USA

2. Department of Medicinal Chemistry and Pharmacognosy; Drug Discovery Program; University of Illinois at Chicago; 833 S. Wood Street Chicago IL 60612 USA

Funder

US National Institutes of Health (NIH)

Wendy Will Cancer Fund

Stand Up To Cancer-Ovarian Cancer Research Fund-Ovarian Cancer National Alliance-National Ovarian Cancer Coalition Dream Team Translational Research Grant

Publisher

Wiley

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics,Molecular Medicine,Drug Discovery,Biochemistry,Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cmdc.201600426/fullpdf

Reference63 articles.

1. Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis

2. XRCC2 and XRCC3, New Human Rad51-Family Members, Promote Chromosome Stability and Protect against DNA Cross-Links and Other Damages

3. Correction of chromosomal instability and sensitivity to diverse mutagens by a cloned cDNA of the XRCC3 DNA repair gene.

4. Targeting the homologous recombination pathway by small molecule modulators

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined inhibition of RAD51 and CHK1 causes synergistic toxicity in cisplatin resistant cancer cells by triggering replication fork collapse;International Journal of Cancer;2024-09-06

2. Design and Spectral Validation of RAD51 Inhibitors Based on BRC4 (1523-1546);Pharmaceutical Chemistry Journal;2024-06

3. Comparative analysis of structural dynamics and allosteric mechanisms of RecA/Rad51 family proteins: Integrated atomistic MD simulation and network-based analysis;International Journal of Biological Macromolecules;2024-03

4. SARS-CoV-2 exploits cellular RAD51 to promote viral propagation: implication of RAD51 inhibitor as a potential drug candidate against COVID-19;Journal of Virology;2023-12-21

5. Synthesis and biological evaluation of DIDS analogues as efficient inhibitors of RAD51 involved in homologous recombination;Bioorganic & Medicinal Chemistry Letters;2023-05